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Dissociation of glomerular filtration and renal blood flow in HgCl
induced acute renal failure. This study evaluates the role of early renal
vasoconstriction in the pathogenesis of mercuric chloride (HgCl2)-
induced acute renal failure (ARE) in the dog. Within 3 hr after mercury,
glomerular filtration rate (GFR), from 45 4 to 25 2 mI/mm, and renal
blood flow (RBF), from 268 22 to 161 19 mI/mm, decreased
simultaneously. A rise in diuresis and urinary solute excretion oc-
curred. Morphological and functional studies excluded a major role for
tubular leakage or obstruction. An attempt was made to prevent the
early renal vasoconstriction, by the administration of Haemaccel®, a
plasma volume expander, alone or in combination with phentolamine.
In both settings the fall in RBF after mercury was prevented. Haemac-
eel® volume expansion alone provoked a significant rise in GFR before
HgCI2, but the GFR fell by 29% 3 hr after HgCI2. The Haemaccel®/
phentolamine combination had no influence on pre-mercury GFR
values. In this group, a decrease of GFR by 44% was noted 3 hr after
mercury. In conclusion, changes in GFR and renal hemodynamics can
be dissociated in the early phase of nephrotoxic ARF. The fall in GFR
can be attributed either to a decrease in glomerular ultrafiltration
capacity and/or changes in glomerular afferent and efferent resistances,
leading to a decrease in glomerular hydrostatic pressure.
Dissociation deJa filtration glomerulaire et celles du debit sanguin renal
dans l'insuffisance rénale induite par HgCl2. Cette étude évalue le rOle de
Ia vasoconstriction rénale précoce dans Ia pathogénie de l'insuffisance
rénale aigue (ARF) indujtc par chlorure de mercure (HgCl2) chez Ic
chien. Trois heures après le mercure, le debit de filtration glomerulaire
(GFR), de 45 4 a 25 2 mI/mm, et le debit sanguin renal (RBF), de
268 22 a 161 19 mi/mm, se sont abaissés simultanCment. Une
augmentation de Ia diurèse et de l'excrCtion urinaire des solutCs est
survenue. Des etudes morphologiques et fonctionnelles ont exclu un
rOle important de Ia fuite tubulaire ou de l'obstruction. Une tentative a
été faite pour prévenir Ia vasoconstriction rénale prCcoce, en adminis-
trant de l'Haemaccel®, une substance permettant l'expansion du vol-
ume plasmatique, seul, ou associC a Ia phentolamine. Dans les deux
cas, Ia chute de RBF aprs Ic mercure a etC évitCe. L'expansion
volémique par l'Haemaccel® seul a provoqué une élévation significative
de GFR avant HgCl2, mais GFR a chute de 29% 3 heures après FlgCl2.
L'association Haemaccel®/phentolammne n'a pas modiflé les valeurs de
GFR avant Ic mercure. Dans cc groupe, une baisse de 44% de GFR a etC
notée 3 heures après le mercure. En conclusion, les modifications de
GFR et de l'hCmodynamique rCnale peuvent être dissociées a Ia phase
précoce d'une ARE néphrotoxique. La chute de GFR est attribuable a
une baisse de Ia capacitC d'ultrafiltration glomCrulaire et/ou a des
modifications des resistances affCrentes et efférentes glomerulaires
aboutissant a une diminution de Ia pression hydrostatique glomerulaire.
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Early renal vasoconstriction is present in most ischemic and
nephrotoxic models of acute renal failure (ARF). It has been
observed after glycerol administration [1—2], renal arterial
clamping [3], the intrarenal infusion of norepinephrine [4, 5],
and after injection with uranyl nitrate [6—8] and mercuric
chloride (HgCI2) [9, 10]. Although the persistence of renal
vasoconstriction does not seem to be directly responsible for
the maintenance phase [11], it has been accepted that reduction
of renal blood flow (RBF) is a major pathogenetic factor in the
initiation of ARF [12].
Recent attempts to define the early role of renal vasoconstric-
tion gave conflicting results. Maintenance of RBF by prosta-
glandin E2 [4], dopamine, or furosemide [13] did not prevent a
fall in glomerular filtration rate (GFR) the first 3 hr after uranyl
nitrate administration. In contrast, a prior infusion of prosta-
glandin E, [4], bradykinin, furosemide, and mannitol [14]
improved renal function in the norepinephrine model. This last
study suggested that increases in osmotic diuresis and natriure-
sis played a more important protective role than changes in
RBF.
The present study investigates the role of renal vasoconstric-
tion in the first 3 hr of a HgCl2 model of ARF in the dog. In
addition, an attempt was made to discern an eventual protective
influence of a resetting of the basal GFR at a higher level before
the nephrotoxic challenge.
To answer these questions, dogs were pretreated with Hae-
maceel®, a gelatin plasma volume expander, resulting in an
increase in both GFR and RBF before the HgCI2 administra-
tion. In another series of experiments this initial rise in GFR
was prevented by the concomitant administration of' phentol-
amine and Haemaccel®.
The results demonstrate that the early fall in GFR in the
initiation of HgCl2-induced acute renal failure can be dissociat.
ed from changes in renal hemodynamics and that a resetting of
the initial GFR at a higher level has no protective effect.
Methods
Studies were performed in 52 mongrel dogs weighing 20 to 38
kg and fed with standard laboratory chow. The animals were
anesthesized with sodium pentobarbital (30 mg/kg of body
weight i.v.). Both femoral veins were cannulated for infusion,
and one femoral artery for blood collections and measurement
of blood pressure. In the dogs receiving Haemaccel®, both the
left brachial and the deep jugular vein were catheterized for
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infusion and monitoring of the central venous pressure (CVP),
respectively. Both ureters were cannulated through a suprapu-
bic incision. An electromagnetic flow probe (I.D. 3 to 5 mm)
was placed on the left renal artery for continuous registration of
RBF. The left renal vein was catheterized via a gonadal vein to
obtain blood for estimation of the para-aminohippurate (PAH)
extraction.
Clearance studies (N = 31). Inulin, creatinine, and PAH
clearances were performed by the continuous infusion tech-
nique as previously described from this laboratory [15]. The
clearance collections were started at least 1 hr after the initial
bolus injection of the markers.
Radioactive microsphere studies (N = 12). In some studies,
additional measurements of total renal and intrarenal hemody-
namics were performed with the radioactive microsphere meth-
od, as previously described in detail [16]. Briefly, for the
injection of the microspheres, the left ventricle was catheter-
ized by a Goodale-Lubin standard wall catheter. Radioactive
microspheres (New England Nuclear Corporation, Boston,
Massachusetts) with a mean diameter of 15 3 s were used.
Two different nuclides, 103Ru and 95Nb, were administered in
the same animal. Approximately 800,000 microspheres were
given with each injection, and blood was simultaneously with-
drawn for 1 mm from the left femoral artery at a constant rate of
7.6 mI/mm. The reference samples were transferred in counting
tubes and the collection syringe was rinsed. This rinse was
added to the counting tube and the tubes were centrifuged to
sediment the microspheres. At the conclusion of the experi-
ments, the kidneys were removed, weighed, sectioned, and
counted as previously described [161. Three tangential sections
of 1 cm thick were obtained from the renal corte. These pieces
were then divided into four equal sections, called zones 1 to 4
(from the most outer to the most inner cortical zone). Each
section was placed in a counting tube and counted in a gamma
counter. Total renal blood flows, corrected percent zonal blood
flows, and absolute zonal perfusion rates were calculated
according to Lameire et al [161 and Stein Ct al [17].
Histologic studies (N = 9). Renal morphology was studied
with light microscopy in five dogs and with scanning electron-
microscopy in four dogs. A catheter was introduced via the
femoral artery above the renal orifices. The aorta was then
ligated proximally and distally to the renal arteries. After
opening the renal veins, the kidneys were perfused during 4 to 6
mm with a phosphate-buffered glutaraldehyde solution at a
mean hydrostatic pressure of 125 mm Hg and at a mean rate of
250 ml/min. At the end of the infusion, the kidneys were
removed, sectioned, and processed. For light microscopy,
cross sections throughout the kidney were stained with hema-
toxylin-eosin. For electronmicroscopy, the specimens were
postfixed in 1% osmium tetroxide, washed in a veronal acetate
buffer, and dehydrated with graded concentrations of ethanol.
The tissue was dried in fluid carbon dioxide in a critical point
dryer. After the specimens were coated with gold, they were
scanned with a JSM-U3 scanning electron microscope that had
an accelerating voltage of 15 KEy.
Experiments were performed in five different groups:
Group 1: HgCI2 alone (N = 9). After control clearance
collections, HgC12 (3 mg/kg in 5 ml of isotonic saline) was
injected intravenously. Three experimental clearance collec-
tions were obtained 1, 2 and 3 hr after the HgCl, administration.
Urinary fluid losses were compensated by equivalent doses of
isotonic saline.
In six additional animals renal hemodynamics were studied
by radioactive microspheres. The spheres were injected in the
control clearance period and 3 hr after HgCl2.
Group 2: Haemaccel® + HgCI2 (N = 10). At the end of the
control collections, a Haemaccel® solution (Behring Werke A.
G., Marburg, West-Germany; composition: a gelatin plasma
substitute 35 g/liter, sodium 145 mEq/liter, potassium 5.1 mEq/
liter, calcium 12.5 mEq/liter, chloride ion 145 mEq/liter) was
intravenously infused at an average rate of 15 mi/mm. When a
rise in electromagnetically recorded RBF was appreciated,
clearance collections were obtained. HgCl2 then was adminis-
tered and experimental clearance collections were obtained as
in group 1. The Haemaccel® administration was adjusted fur-
ther to stabilize the RBF at this level.
Group 3: Haemaccel® + phentolamine (Regitine®) + HgC12
(N 6). After control collections, Flaemaccel® was adminis-
tered as in group 2. Fifteen minutes later, an intravenous bolus
injection of phentolamine (Ciba Geigy, Basle, Switzerland) was
given in a dose of 0.1 mg/kg, followed by a continuous infusion
of 5 ig/kg/min. The efficacy of the alpha-blockade was tested
by a norepinephrine injection of 1 g/kg/min over a 10-mm
period. The hypertensive reaction and renal vasoconstriction
normally occurring after norepinephrine was also blunted
completely.
Fifteen minutes after the bolus injection of phentolamine,
clearance collections were obtained, HgC12 was administered,
and experimental clearances were collected as in group I. In six
additional dogs, microspheres were injected immediately prior
to and 3 hr after the HgC12 administration.
Group 4: Haemaccel® alone (N = 3). At the end of the
control clearances, Haemaccel® was infused during 3 hr as in
group 2, but no HgCl2 was administered. Experimental clear-
ance collections were obtained 1, 2 and 3 hr after the start of
Haemaccel®.
Group 5: Haemaccel® + phentolamine (N = 3). Haemaccel®
and phentolamine were administered during 3 hr as in group 3
without HgCl2 injection. Experimental clearance collections
were obtained 1, 2 and 3 hr after the initiation of the phentol-
amine administration.
The results are expressed as means SEM for one kidney,
and Student's t test was applied to compare the different
experimental results.
Results
Group 1: HgCI2 alone. The results of these studies are
summarized in Table 1. A progressive fall in GFR and calculat-
ed RBF and unchanged PAH extractions (EPAH) are noted over
the 3-hr period. The electromagnetically measured RBF in both
control and experimental periods correlates well with the values
obtained with the clearance technique (r = 0.99; P < 0.001). On
the other hand, diuresis, fractional excretion of sodium (FENa),
and urinary osmolar excretion (UVüsm) progressively increase.
The urine to plasma creatinine to inulin ratios are 1.01 0.03 in
control and 0.98 0.08, 0.99 0.05, and 0.98 0.05 at 1, 2 and
3 hr postmercury (P > 0.05). The corresponding mean U/P
inulin values are 233 40, 56 20, 14 2, and 11 2,
respectively.
The microsphere studies in this group are summarized in
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Table 1. Summary of HgCl2 studies (N = 9)a
30 to 60 mm
after HgCI, I .64h
UV GFR EPAH RBF FF FEN, UV0 MAP
mi/mm mi/mm % mi/mm % % pOsm/min mm Hg
SEM 0.45 4
90 to 120 mm
after HgCI2 2.63°
SEM 0.42 3
150 to 180 mm
after HgCI2 2.49c
19
Abbreviations: UV, urine flow; GFR, glomerular filtration rate; EPAH, PAH extraction; RBF, renal blood flow; FF, filtration fraction, FENa,
fractional sodium excretion; UV0, urinary osmolar excretion; MAP, mean arterial pressure.
a Results are given as mean SEM.
F P < 0.05 (vs. control period Student's / test).
P < 0.01 (vs. control period).
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Fig. 1. Microsphere studies in groups 1 (upper panel) and 3 (lower
panel). Fractional renal zonal cortical blood flow distribution, total
renal blood flow and glomerular filtration rate before and 3 hr after
mercuric chloride are represented. Symbols are: °, P < 0.05 vs. control
period; **, P<0.01 vs. control period; E, Control; ,3 hr after HgCl2;
, Haemaccel.
Figure 1, upper panel. A fall of 56% in total RBF and of 46% in
GFR, 3 hr after HgCI2 is noted. The absolute blood flow
decreases significantly 3 hr postmercury in all four cortical
zones.
Light microscopial studies in the glomeruli (Fig. 2) demon-
strated a mesangial reaction and a slightly hyperplasticjuxtaglo-
merular apparatus. The surrounding tubules were open and no
cast formation was detected. Apical bleb formation with thin-
ning and loss of the brush border and discrete vacuolar degener-
ation of the cells was observed in the proximal tubules. The
collecting ducts did not show any cast formation, and no
interstitial or vascular alterations were present.
As compared to the control situation (Fig. 3; upper panel),
scanning electron microscopy of the glomerular structures 3 hr
after HgCl2 revealed minor swelling of the microvilli on the
surface of the cell body of the visceral epithelium (Fig. 3; lower
panel). Thus, acute administration of HgCI2 causes a parallel
decrease in GFR and RBF (Fig. 4, upper panel), and an increase
in urine flow (UV) and urinary solute excretion. Redistribution
of fractional regional blood flow is not responsible for the
filtration disturbances seen within the first 3 hr after HgCl2.
Group 2: HgCI2 + Haemaccel® studies. The results are
summarized in Table 2. The GFR increases significantly by
administration of Haemaccel® alone, After the injection of
HgCl2, however, a progressive decrease is observed. In con-
trast, the calculated RBF remains constant. A similar increase
in UV, FEND and UVO as in group I was also noted after
mercury.
It is clear that Haemaccel® plasma volume expansion and
associated enhancement of RBF before HgCl2 cannot prevent a
progressive fall in GFR after mercury. Compared to the Hae-
maceel® period, the fall in GFR was 29%, (Fig. 4, middle panel),
and compared to the hydropenic period, the fall was 20%, 3 hr
after HgCl2.
Group 3: Haemaccel® + phentolamine + HgCI2 studies. The
results are summarized in Table 3. In contrast with the pre-
HgC12 values of group 2, the GFR remains constant when a
concomitant administration of Haemaccel and phentolamine is
used. However, after HgCI2, the GFR decreases progressively
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Fig. 2. Light microscopic studies. Morphologi-
cal aspect of the superficial cortical (upper
panel) and the deep medullary tissue (lower
panel) 3 hr after mercury. Minor apical bleb
formation is present in the proximal tubules;
no important intratubular cast formation is vi-
sualized in either cortical or medullary struc-
tures. (Hematoxylin-eosin, x 160).
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to the same extent as in group 1, despite an unchanged RBF.
Important increases in FENa, UV, and UVsm are observed in
the postmercury periods.
As can be appreciated from the lower panel of Figure 1, there
are some moderate but significant changes in the corrected
procentual intrarenal blood flow distribution. However, calcu-
lation of the absolute zonal blood flows revealed no changes
between control and 3 hr postmercury values: RBF in zone 1,
167 26 vs. 206 34 mI/mm; zone 2, 134 23 vs. 220 38 ml!
mm; zone 3, 77 9 vs. 126 25 mi/mm; and zone 4, 38 7 vs.
42 14 mllmin (P > 0.05 for all values).
Thus, despite a constant total RBF and an unchanged abso-
lute blood flow in each zone, the GFR 3 hr postmercury
progressively decreased and to the same degree as in the
unpretreated animals (Fig. 4, lower panel) ( GFR of —44% in
group 3 versus GFR of —40% in group I).
Group 4: Haemaccel® alone. Table 4 summarizes the results
obtained in this group. The administration of a comparable
amount of Haemaccel®, as in the HgCl2-treated animals, caused
a constant but insignificant increase in GFR with a mean of
13%. The other parameters change as can be expected after an
acute volume expansion.
Group 5: Haemaccel® + phentolainine studies. Table 5
summarizes the results obtained in this group. As can be noted,
—t--'
4 4 1.
''S
Fig. 3. Scanning electron microscopy studies of the glomerulus in
control hydropenic dog (upper panel) and 3 hr (fter HgCI2 (lower
panel). Minor swelling of the epithelial structures is seen after mercury.
(x5000),
this combination is not associated with a change in GFR.
Arterial blood pressure remains constant. FENa, UVosm and
UV are enhanced as markedly as in group 4.
Discussion
Four major mechanisms have been proposed to explain the
fall in GFR in both human and experimental ARF: tubular
obstruction and/or back-leak, renal vasoconstriction, and a
decreased glomerular ultrafiltration coefficient (Kf) [lii. The
10
C',
—10
-20
HgC12 model has been particularly well studied [9, 18—20),
probably because it has direct relevance to the clinical situation
of toxic ARF. Most of the studies were performed in a later
stage of renal damage, when oligoanuria was established.
The present study evaluates the role of renal hemodynamics
in the early phase of RgCI2-induced ARF. Three experimental
groups of animals were used: a control group where the effect of
HgCI2 alone was tested, and two other groups of animals where
the postmercurial renal vasoconstriction, observed in the first
experiments, was prevented by previous acute volume expan-
sion with Haemaccel® alone or in combination with
phentolamine.
Haemaccel® was chosen because it provokes a rise in GFR
when administered in sufficient amounts [21, 22].
In the third series, an attempt was made to prevent the fall in
RBF without this concomitant rise in GFR in the pre-experi-
mental period. Therefore, phentolamine was added to the
Haemaccel® because from studies published by Hodler et al
[23), it could be presumed that phentolamine causes a modest
decrease in GFR without changing the renal perfusion. As can
be judged from Table 3, the increase in GFR was indeed
prevented without alteration in renal blood flow in the premer-
curial period. An additional reason to include an alpha-blocking
agent in this study was provided by previous results of Solomon
and Hollenberg [241 who demonstrated that HgCI2 causes a
direct renal vasoconstriction which could be attenuated with
phentolamine. The main finding of the present study is that a
complete dissociation between GFR and RBF could be realized
and that a constant or enhanced RBF did not prevent a fall in
postmercury GFR.
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Fig. 4. Procentual changes in GFR and RBF as compared to the control
period in groups I (upper panel), 2 (middle panel), and3 (lower panel).
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Table 2. Summary of HgCI2 + Haemaccel® studies (N = l0)a
UV GFR EPAH RBF FF UV0
mI/mm mi/mm % mI/mm % FENa % ,uOsm/min
MAP
mm Hg
CVP
cm H20
Control 0.32 45 82 297 26 0.71 306 130 2
SEM 0.09 4 6 48 2 0.19 62 4 1
Control Haemaccel® 0.77" 51" 80 312 26 1.47 491" 143C 3
SEM 0.16 4 6 31 2 0.32 64 4 1
30 to 60 mm after
HgCI2 6.71" 50b 71 316 25 l0.27" 1775 154" 6b
SEM 1.32 3 7 32 3 2.85 420 5 1
90 to 120 mm after
HgC12 8.20" 43C 69 329 20" 18.40CC 2643" 151C 4b
SEM 0.85 3 7 32 2 2.96 269 3 1
150 to 180 mm after
HgCI2 6.75C 36'' 64" 335 16"' 20.81" 2475CC 148C 5C
SEM 0.79 3 10 39 2 2.62 232 5 1
Same abbreviations as in Table 1; CVP, central venous pressure.
"P < 0.05 (vs. control period).
P < 0.01 (vs. control period).
"P < 0.05 (vs. control Haemaccel® period).
P < 0.01 (vs. control Haemaccel® period).
Table 3. Summary of HgCl2 + Haemaccel® + phentolamine studies (N =
UV GFR EPAH RBF FF FENa MAP CVP
mI/mm mI/mm % mI/mm % % p.Osmlmin mm Hg cm H20
Control 0.29 64 79 470 26 0.28 298 126 2
SEM 0.04 6 5 48 4 0.09 50 2 2
Control Haemaccel®
+ phentolamine 2.29 64 80 447 27 1.48" 663C 130 5
SEM 0.95 9 4 37 3 0.45 144 5 3
30 to 60 mm
after HgCI2 6.81Cd 51" 78 483 17b,C 10.39CC 2373CC 132 5
SEM 0.85 8 4 104 2 1.67 521 6 3
90 to 120 mm
after HgCI2 8.79Cd 42CC 78 480 l31,C 20.25" 3277CC 131 5
SEM 1.27 5 4 65 2 2.64 467 7 4
150 to 180 mm
after HgCI2 8.21'' 36CC 71" 473 12CC 21.45CC 2887CC 131 5
SEM 0.96 6 5 37 2 1.97 206 6 3
Same abbreviations as in Table 2.
b P < 0.05 (vs. control period).
C P < 0.01 (vs. control period).
"P < 0.05 (vs. control Haemaccel® + phentolamine period).
a p < 0.01 (vs. control Haemaccel® + phentolamine period).
In hydropenic rats, an early redistribution of cortical blood
flow resulting in preferential outer cortical ischemia occurs
after HgCI2, as demonstrated by Hsu et at [25] and Lameire,
Ringoir, and Leusen [20]. In the present study, no redistribution
occurs in fractional regional blood flow within the first 3 hr after
HgCl2 administration. In the volume-expanded dogs, the abso-
lute zonal blood flow also remained unchanged. These findings,
together with the results obtained in the uranyl nitrate model [4,
13], suggest a minor role of cortical blood flow distribution in
the early phase of nephrotoxic ARF.
It is known that nephron damage in ARF can be heteroge-
neous and although intrarenal blood flow did not show redistri-
bution, changes in individual glomerular perfusion with under-
perfusion in some and superperfusion in the other nephrons,
could have occurred. This phenomenon possibly could not have
been detected with the microsphere technique and therefore
cannot be excluded entirely.
One other possible mechanism that at least partially can
explain the present findings is that the volume expansion in
association with HgCI2 has maintained a normal overall renal
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Table 4. Summary of Haemacce1" studies (N 3)
30 to 60 mm
after start
Haemaccel®
SEM
90 to 120 mm
after start
Haemacce1
SEM
150 to 180 mm
after start
Haemaccel
+ SCM
UV GFR
rn//ruin mi/mm
3
Abbreviations are the same as in Table 2.
b P < 0.05 (vs. control period).
EPAH RBF FF FENC
mi/mm
76 372 26 0.84
4 25 3 0.59
67 66 620
7 1
71 67 672"
16 1.89 779
53 1 0.60 142
13 5.08 1558
36 4 1.43 378
61 740 11 5.42
13 98 2 1.42
MAP CVP
uOsm/min mm Hg cmH,O
Table 5. Summary of Haemaccel + phentolamine studies (N = 3)C
30 to 60 mm
after start
+ SCM
90 to 120 mm
after start
SEM
ISO to ISO mm
after start
SCM
UV GFR EPAH
mi/mm ,nl/min %
Same abbreviations as in Table 2.
h EPAH was obtained in only one experiment.
P < 0.05 (vs. control period).
P < 0.01 (vs. control period).
RBF FF FENC
mi/mm %
90 376 33 0.52
137 4 0.20
78 491 20' 4.88
263 3 1.96
71 574 14' 6.72
296 3 1.42
73 554 14' 6.94
267 1 1.26
MAP CVP
uOm/min mm Hg cmH,O
vascular resistance, mainly by an action on the efferent arterio-
lar vascular tone. Acute volume expansion in normal rats alone
provokes a decrease in both afferent and efferent resistance
[261, but it is conceivable that the additional administration of
HgCl2 results in a selective vasoconstriction of the glomerular
afferent arteriole. The combination of both hemodynamic ef-
fects could substantially reduce the glomerular capillary hydro-
static pressure, resulting in a decreased effective glomerular
filtration pressure. The eventual role of a decrease of ultrafiltra-
tion coefficient (Kf) in the pathogenesis of HgCI2-induced ARF
indirectly has been suggested by Baehler et al [9]. The same
investigators also observed a fall in RBF which could not be
invoked in the maintenance of oliguria since acute Ringer
loading supernormalized the renal perfusion without any dis-
cernable effect on glomerular filtration. More direct arguments
for a role of a decrease in Kf were proposed in other nephro-
toxic models such as uranylnitrate [271 and gentamicin [281 in
the rat. As far as we know changes in Kf have not yet been
examined directly in the model of HgCI2-induced ARF. Be-
cause of the ultrastructural changes in the glomerular structures
observed after HgCl2 (Fig. 3), the present study certainly can
not exclude such a role.
An important degree of tubular back-leakage could also offer
an explanation of the low GFR in ARF [181. However, studies
by Olbricht et al found an almost complete urinary recovery of
microinjected inulin 3 to 12 hr after mercury was injected in the
rat [291.
The equal urinary to plasma ratios of inulin to creatinine after
mercury in this study suggest no significant alteration in selec-
tive tubular permeability to these two molecules with widely
different molecular weights (creatinine:113; inulin:5000) and
free diffusion coefficients. If tubular permeability is significant-
Control
SCM
60
5
0.39
0.21
1.08
0.22
4.20
1.64
4.76
2.15
69
10
374
130
130
4
2
3
148 9
3
153" 12
7 3
IS1692
512
149
17
Control
SEM
3
0.25
0.04
2.89
1.38
4.10
0.98
4.27"
0.76
58
IS
62
12
61
10
61
12
276 131 1
45 12 2
918 135 5
458 9 1
1246 137 S
477 14 4
1261 137 9
415 14 6
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ly altered by mercury, then more creatinine than inulin might
leak through the tubular epithelium. It could be argued that the
tubular leak could be larger than the molecular diameter of
inulin (12 A). In fact, openings in the tubular epithelium of 30 A
diameter have been suggested indirectly in dextran studies in
ischemic postoperative human ARF [301. However, these re-
sults were obtained in the maintenance phase of ARF, when the
patients were relatively anuric. In contrast, in our experiments
the fall in GFR was associated with a substantial rise in diuresis.
Furthermore, recent experiments in our laboratory [31] show an
almost complete protection in GFR after HgCI2 in isotonic
mannitol pretreated animals. This observation is quite incom-
patible with a substantial leak for mannitol, a molecule much
smaller than inulin. In addition, the unchanged renal PAH
extraction is difficult to reconcile with the existence of back-
leakage.
Evidence for some degree of tubular obstruction in the early
phase of HgCl2-induced ARF in the rat has been found by
Flamenbaum et a! [19] and Mason et al [32] who reported
normal tubular pressures although a decreased GFR existed.
However, it was felt that the values of tubular pressures
obtained were insufficient to stop glomerular filtration, leading
to the conclusion that tubular obstruction, if any, is rather a
secondary mechanism [33J. Also, no increase in tubular pres-
sure in dogs was observed the first 6 hr after uranylnitrate [6].
In addition, measurements in our laboratory of intracortical
catheter pressure the first 3 hr after HgCl2 in dogs show a
substantial and progressive fall in this indirect estimation of
proximal tubular pressure [31].
Detailed morphological analysis did not reveal important
tubular obstruction in any nephron segment, which could
explain a fall in GFR of 40 to 50%.
Finally, our results allow us to comment on the "protective"
effect of a previous increase in GFR before a nephrotoxic insult.
It is obvious that a resetting of the GFR at a higher control level
does not prevent a deterioration of that renal function to a
similar degree (Table 2).
In conclusion, this study demonstrates that in the early
polyuric phase of nephrotoxic ARF, a parallel decrease in both
GFR and RBF occurs. However, the changes in GFR and in
renal hemodynamics can be dissociated so that alterations in
total RBF do not seem to play an important pathogenic role.
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